shopping cart
nothing in cart
 
browse by subject
new releases
best sellers
sale books
browse by author
browse by publisher
home
about us
upcoming events
Jun 1st - Certificate in Trauma Counselling for Mental Health Professionals: Level 1 trauma certificate [SickKids CCMH Learning Institute]
Jun 4th - Certificate in Cognitive Behaviour Therapy Level 1: Practical solutions to real world problems - live webinar [SickKids CCMH Learning Institute]
Jun 9th - Hack Your Mind for Better Health [MAGentix]
Jun 10th - Tips, Tricks and Techniques for Online Therapy with Children - live 2-hour webinar [SickKids CCMH Learning Institute]
Jun 12th - It’s the Law: What You Need to Know about Consent, Negligence, Confidentiality and more! - webinar [Leading Edge Seminars]
schools agencies and other institutional orders (click here)
Free shipping across Canada, for the foreseeable future. Please read our Covid-19 statement here.
Join our mailing list! Click here to sign up.
Pharmacotherapy of Child and Adolescent Psychiatric Disorders, Third Edition
Rosenberg David R. and Samuel Gershon (Eds)
Wiley / Hardcover / 2012-02-01 / 0470973765
Psychopharmacology / Child Psychiatry
price: $133.00 (may be subject to change)
474 pages
Not in Stock, usually ships in 7-10 business days

This book fulfils an urgent need for an updated text on pediatric psychopharmacology. It takes a unique approach in discussing recent findings within the context of current issues, including economic and political ones. The book covers the emerging question of treating children who do not yet meet diagnostic criteria for psychosis, e.g, schizophrenia or bipolar disorder, but who are deemed to be at high risk. This is an active area of debate: such children are being treated in certain centers, while others reject this completely. The book addresses the antidepressant controversy, the placebo response and unique strategies for delineating this, and ways to optimize the differential between active medication and placebo. It reviews the impact of recent American Heart Association guidelines for monitoring children on stimulants and other psychotropics. It adheres closely to DSM-IV diagnostic criteria throughout. The book describes the use of newly approved drugs such as Lexapro for treating adolescent depression and the novel compound Intuniv. It covers the TADS and CAMS studies, which evaluated the use of SSRIs alone and in combination with cognitive behavioral therapy for adolescent depression. Other topics include treatment of bipolar disorders, the increasing popularity of generic equivalents, combination pharmacotherapy and the potential dangers of psychotropic medications.Third edition of the first ever book published on pediatric psychopharmacology from renowned editors.Incorporates current developments with regard to SSRIs, their indications and their safety issues, including possible associated suicidal behavior.Addresses concerns about cardiovascular side effects of the new stimulant medications available, and compares to other FDA-approved medications for ADHD.Features many tables, figures and pictorials, making it highly accessible and reader friendly.

About the Editors:

David Rosenberg MD, Miriam L. Hamburger Endowed Chair of Child Psychiatry and Professor & Chief of Child Psychiatry and Psychology at Wayne State University and the Children's Hospital of Michigan, Detroit, MI , USA

Samuel Gershon MD, Emeritus Professor of Psychiatry, University of Pittsburgh, PA, USA

Caversham Booksellers
98 Harbord St, Toronto, ON M5S 1G6 Canada
(click for map and directions)
All prices in $cdn
Copyright 2020

Phone toll-free (800) 361-6120
Tel (416) 944-0962 | Fax (416) 944-0963
E-mail [email protected]
Hours: 9-6 Mon-Sat / Closed Sunday (EST)

search
Click here to read previous issues.
other lists
Child Psychiatry
Child Psychiatry Review
Print-on-Demand Titles
Psychopharmacology
Wiley